Galectin‐3, A Potential Therapeutic Target for Rheumatoid Arthritis?

Qiang Xie,Ming Ni,S. Wang
DOI: https://doi.org/10.1111/sji.12631
2018-01-01
Scandinavian Journal of Immunology
Abstract:Recently, we read with great interest the article by Issa, et al., who showed that baseline galectin-3 was significantly increased in patients with anti-CCP-positive rheumatoid arthritis (RA) when compared to anti-CCP-negative patients and healthy controls 1. Moreover, expression of galectin-3 correlated with baseline smoking, anti-CCP and with MRI erosion score after 1 year of follow-up. These data indicated that galectin-3 is closely linked to autoimmunity in RA, and may play an important role in the pathogenesis of RA. RA is a phenotypically heterogeneous, chronic, destructive inflammatory disease of the synovial joints, characterized by the presence of autoantibodies in a significant majority of patients. Arthritic mice model underwent non-invasive in vivo PET/MRI showed enhancement in hypoxia tracer uptake, and inflammation in joints 2. Galectin-3 is a 26 kD beta-galactoside-binding protein. It is expressed in a number of cell types, such as macrophages, monocytes and dendritic cells. Forsman et al. found that joint inflammation, bone erosion, the frequency of IL-17-producing cells in the spleen of antigen-induced arthritis (AIA) mice were significantly suppressed in galectin-3-deficient (-/-) mice as compared with wild-type mice, and galectin-3-/- mice showed decreased levels of antigen-specific IgG and pro-inflammatory cytokines. Interestingly, exogenously added recombinant galectin-3 could restore the reduced arthritis and cytokines in galectin-3-/- mice 3. Galectin-3 expression in RA patients’ synovial fibroblasts inhibited by siRNA showed down-regulated TLR-2-, -3- and -4-induced IL-6 secretion 4. Moreover, intra-articular lentivirus-mediated delivery of galectin-3 siRNA into the ankle joints of rats with collagen-induced arthritis (CIA) showed higher percentages of antigen-induced T cell death in the lymph node cells from arthritic rats. The treatment significantly reduced articular index scores, radiographic scores and histological scores, accompanied by reduced T cell infiltrates and down-regulated microvessel density in the ankle joints 5. Taken together, available evidences suggest an important role of galectin-3 in the pathogenesis of RA. However, the accurate mechanisms of galectin-3 in the pathogenesis of RA need to be established. Consequently, further studies are required, especially in human systems, to comprehensively explore the role of galectin-3 in arthritis. The development of therapeutic agents targeting galectin-3 might result in important new, innovative therapies for the treatment of RA. None. QX, MN and SW drafted the manuscript. All authors read and approved the final manuscript. The authors have no potential conflict of interests.
What problem does this paper attempt to address?